Drawing upon decades of experience, RAND provides research services, systematic analysis, and innovative thinking to a global clientele that includes government agencies, foundations, and private-sector firms.
The Pardee RAND Graduate School (PardeeRAND.edu) is home to the only Ph.D. and M.Phil. programs offered at an independent public policy research organization—the RAND Corporation.
Assistant Policy Researcher; Ph.D. Candidate, Pardee RAND Graduate School
Ph.D. Candidate, Pardee RAND Graduate School, and Assistant Policy Researcher, RAND
Journal Article
Environmental factors may mediate the transformation of latent prostate cancer into clinically apparent tumors.
Jan 1, 2005
The UCSF-CAPRA score is a straightforward yet powerful preoperative risk assessment tool.
Assessing bowel function (BF) in prostate cancer can help determine therapeutic trade-offs.
This work provides new insights into HRQOL over time in a low-income, multiethnic group of patients with prostate cancer.
The objective was to describe health-related quality-of-life (HRQOL) in low-income men with prostate cancer.
To describe and compare health related quality of life (HRQOL) among Hispanic, African-American, and Caucasian men with localized prostate cancer.
Economically disadvantaged men with prostate cancer report worse mental health than people with other chronic diseases.
Being partnered confers benefits in survival for patients with prostate cancer, yet little is known of the impact of relationship status on HRQOL.
The authors found no socioeconomic or demographic disparities in the receipt of postprostatectomy radiotherapy.
Men with lower pretreatment quality-of-life measures may be at increased risk of fatigue after prostate cancer treatment
Younger patient age (less than 65) is associated with a greater likelihood of returning to baseline continence, potency and physical health after radical prostatectomy.
Jan 1, 2004
Geographic variation persists in patterns of care in men with early stage prostate cancer.
This study establishes a foundation on which to build quality-of-care assessment tools to evaluate the treatment of early-stage prostate cancer.
Jan 1, 2003
Quality of life is of great concern to patients considering treatment options for prostate cancer.
These model-based lead-time estimates support a prostate cancer screening interval of more than 1 year.
Men diagnosed with metastatic prostate cancer during the follow-up after treatment for clinically localized disease report a better quality of life.
Physician support and prostate cancer screening knowledge were positively associated with previous screening.
The authors aimed at developing and testing a Dutch health-related quality of life measure for localized prostate cancer patients.
The goal of quality assurance in health care is to preserve and improve patient care.
Study to ascertain whether radical prostatectomy outcomes improved after the diffusion of surgical innovations during the last decade.
